Taner TURAN, Caner ÇAKIR, Dilek YÜKSEL, Çiğdem KILIÇ, Mehmet ÜNSAL, Alper KARALÖK, Günsu KİMYON CÖMERT, Osman TÜRKMEN, Fatih KILIÇ

Risk factors for evisceration in gynecological oncology surgeries

Background/aim: To investigate the risk factors for evisceration in a gynecological oncology population. The secondary aim was to evaluate the impact of evisceration on survival. Materials and methods: Inclusion criteria consisted of having had an elective surgery performed through a xiphoidopubic incision in our institution and having a gynecological malignancy based on pathology. A total of 198 patients were evaluated, 54 with evisceration and 144 without evisceration. Due to the widely varied prognosis of female genital cancers, the survival was analyzed on a homogenized group, including only 62 patients with primary advanced stage epithelial ovarian-tubal-peritoneal cancer. Results: The preoperative factors associated with evisceration in the univariate analysis were old age, high body mass index (BMI), hypertension, smoking, comorbidities, high American Society of Anesthesiologist (ASA) score (3 and 4), and low preoperative albumin level. The associated intraoperative factors were bleeding volume, receiving more than two units of erythrocyte suspension or fresh frozen plasma, and having had a major operation. The associated postoperative factors were the albumin transfusion and the antibiotic use in the early postoperative period. In the multivariate analysis, smoking, low levels of preoperative albumin, high BMIs, and high ASA scores (3 and 4) were independent prognostic factors for evisceration. Evisceration was not associated with recurrence and survival in the patients with primary advanced stage epithelial ovarian-tubal-peritoneal cancer. Conclusion: Smoking, preoperative hypoalbuminemia, obesity, and high ASA scores (3and 4) were the prognostic factors for evisceration. Short-term modifiable factors such as smoking cessation and improved nutritional status should be considered in elective gynecological oncology surgeries. Evisceration had no impact on survival and recurrence in the patients with primary advanced stage epithelial ovarian-tubal-peritoneal cancer.Key words: Evisceration, hypoalbuminemia, obesity, smoking, survival, wound dehiscence

PDF

___

1. Kenig J, Richter P, Zurawska S, Lasek A, Zbierska K. Risk factors for wound dehiscence after laparotomy - clinical control trial. Polski Przeglad Chirurgiczny 2012; 84 (11): 565-573. doi: 10.2478/v10035-012-0094-0
2. Walming S, Angenete E, Block M, Bock D, Gessler B et al. Retrospective review of risk factors for surgical wound dehiscence and incisional hernia. BMC Surgery 2017; 17 (1): 19. doi: 10.1186/s12893-017-0207-0
3. Van Ramshorst GH, Nieuwenhuizen J, Hop WC, Arends P, Boom J et al. Abdominal wound dehiscence in adults: development and validation of a risk model. World Journal of Surgery 2010; 34 (1): 20-27. doi: 10.1007/s00268-009-0277-y
4. Pavlidis TE, Galatianos IN, Papaziogas BT, Lazaridis CN, Atmatzidis KS et al. Complete dehiscence of the abdominal wound and incriminating factors. The European Journal of Surgery 2001; 167 (5): 351-354. doi: 10.1080/110241501750215221
5. Van Ramshorst GH, Eker HH, Van Der Voet JA, Jeekel J, Lange JF. Long-term outcome study in patients with abdominal wound dehiscence: a comparative study on quality of life, body image, and incisional hernia. Journal of Gastrointestinal Surgery 2013; 17 (8): 1477-1484. doi: 10.1007/s11605-013- 2233-2
6. Aksamija G, Mulabdic A, Rasic I, Aksamija L. Evaluation of risk factors of surgical wound dehiscence in adults after laparotomy. Medical Archives 2016; 70 (5): 369-372. doi: 10.5455/medarh.2016.70.369-372
7. Shanmugam VK, Fernandez SJ, Evans KK, McNish S, Banerjee AN et al. Postoperative wound dehiscence: Predictors and associations. Wound Repair and Regeneration 2015; 23 (2): 184-190. doi: 10.1111/wrr.12268
8. Webster C, Neumayer L, Smout R, Horn S, Daley J et al. Prognostic models of abdominal wound dehiscence after laparotomy. The Journal of Surgical Research 2003; 109 (2): 130-137. doi: 10.1016/s0022-4804(02)00097-5
9. Rodriguez-Hermosa JI, Codina-Cazador A, Ruiz B, Roig J, Girones J et al. Risk factors for acute abdominal wall dehiscence after laparotomy in adults. Cirugia Espanola 2005; 77 (5): 280- 286. doi: 10.1016/s0009-739x(05)70854-x
10. Goltsman D, Munabi NC, Ascherman JA. The association between smoking and plastic surgery outcomes in 40,465 patients: An analysis of the American College of Surgeons National Surgical Quality Improvement Program Data Sets. Plastic and Reconstructive Surgery 2017; 139 (2): 503-511. doi: 10.1097/PRS.0000000000002958
11. Dahl RM, Wetterslev J, Jorgensen LN, Rasmussen LS, Moller AM et al. The association of perioperative dexamethasone, smoking and alcohol abuse with wound complications after laparotomy. Acta Anaesthesiologica Scandinavica 2014; 58 (3): 352-361. doi: 10.1111/aas.12270
12. Khullar D, Maa J. The impact of smoking on surgical outcomes. Journal of the American College of Surgeons 2012; 215 (3): 418-426. doi: 10.1016/j.jamcollsurg.2012.05.023
13. Dubay DA, Franz MG. Acute wound healing: the biology of acute wound failure. The Surgical Clinics of North America 2003; 83 (3): 463-481. doi: 10.1016/S0039-6109(02)00196-2
14. Laky B, Janda M, Cleghorn G, Obermair A. Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. The American Journal of Clinical Nutrition 2008; 87 (6): 1678-1685. doi: 10.1093/ajcn/87.6.1678
15. Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A et al. ESPEN guidelines on parenteral nutrition: surgery. Clinical Nutrition 2009; 28 (4): 378-386. doi: 10.1016/j.clnu.2009.04.002
16. Kenig J, Richter P, Lasek A, Zbierska K, Zurawska S. The efficacy of risk scores for predicting abdominal wound dehiscence: a case-controlled validation study. BMC Surgery 2014; 14 (1): 65. doi: 10.1186/1471-2482-14-65
17. Ataseven B, Du Bois A, Reinthaller A, Traut A, Heitz F et al. Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery. Gynecologic Oncology 2015; 138 (3): 560-565. doi: 10.1016/j. ygyno.2015.07.005
18. Nugent EK, Hoff JT, Gao F, Massad LS, Case A et al. Wound complications after gynecologic cancer surgery. Gynecologic Oncology 2011; 121 (2): 347-352. doi: 10.1016/j. ygyno.2011.01.026
19. Bohl DD, Shen MR, Mayo BC, Massel DH, Long WW et al. Malnutrition predicts infectious and wound complications following posterior lumbar spinal fusion. Spine 2016; 41 (21): 1693-1699. doi: 10.1097/BRS.0000000000001591
20. Obermair A, Hagenauer S, Tamandl D, Clayton RD, Nicklin JL et al. Safety and efficacy of low anterior en bloc resection as part of cytoreductive surgery for patients with ovarian cancer. Gynecologic Oncology 2001; 83 (1): 115-120. doi: 10.1006/ gyno.2001.6353
21. Asher V, Lee J, Bali A. Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer. Medical Oncology 2012; 29 (3): 2005-2009. doi: 10.1007/ s12032-011-0019-5
22. Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer NT et al. A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients. Gynecologic Oncology 2014; 134 (2): 233- 237. doi: 10.1016/j.ygyno.2014.06.012
23. Correa NF, de Brito MJ, de Carvalho Resende MM, Duarte MF, Santos FS et al. Impact of surgical wound dehiscence on healthrelated quality of life and mental health. Journal of Wound Care 2016; 25 (10): 561-570. doi: 10.12968/jowc.2016.25.10.561